Hunan Nucien Pharmaceutical Co., Ltd. (SHA:688189)
China · Delayed Price · Currency is CNY 8.66
-0.09 (-1.03%)
Feb 11, 2026, 4:00 PM EST
SHA:688189 Market Cap
SHA:688189 has a market cap or net worth of 2.31 billion as of February 13, 2026. Its market cap has increased by 36.20% in one year.
Market Cap
2.31B
Enterprise Value
1.97B
Revenue
95.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.66
Market Cap Chart
Since March 26, 2020, SHA:688189's market cap has decreased from 9.11B to 2.31B, a decrease of -74.64%. That is a compound annual growth rate of -20.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 2.31B | 6.40% |
| Dec 31, 2025 | 2.17B | 21.75% |
| Dec 31, 2024 | 1.78B | -31.04% |
| Dec 29, 2023 | 2.59B | -23.51% |
| Dec 30, 2022 | 3.38B | -31.39% |
| Dec 31, 2021 | 4.93B | -27.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Landfar Bio-medicine | 2.86B |
| Shandong Sito Bio-technology | 2.83B |
| Shanghai Serum Bio-Technology | 2.82B |
| Jiangsu CoWin Biotech | 2.80B |
| Jilin Jian Yisheng Pharmaceutical | 2.76B |
| Jiangsu Sihuan Bioengineering | 2.68B |
| Hubei Goto Biopharm | 2.47B |
| Guiyang Xintian Pharmaceutical | 2.46B |